U.S. FDA panel backs booster shot for Johnson & Johnson COVID-19 vaccine


FDA’s reviewers discovered no new protection issues after a 2d dose of J&J in opposition to COVID-19, however they cautioned in regards to the small selection of sufferers studied and brief follow-up duration.

Leave a Reply

Your email address will not be published. Required fields are marked *